Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.66 -0.15%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.15 million.
GUIDANCE:
Harvard Bioscience sees Q1 2025 revenue of $19-21 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Boeing lands two U.S. defense contracts worth over $711M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
